has over 45 years extensive experience within the healthcare
industry, including innovator R&D pharmaceuticals, OTC
and generic companies and working with Government departments,
law firms, venture capital companies and industry associations.
Heading up the global generics arm of QuintilesIMS
Thought Leadership Alan is responsible for developing services
and insights for the industry and its associations on generic
medicines and biosimilars through a combination of consulting,
information and market analyses.
Previous positions held include Executive
Vice-President, Europe Generics, for Dr Reddy’s Laboratories
Ltd; Vice-President of Global Corporate Strategy for PLIVA
(now Teva); European Marketing Director for Medeva (now UCB);
General Manager, Rhône-Poulenc Rorer UK (now Sanofi);
General Manager, Institute Mérieux UK; and management
roles with Servier Laboratories and SmithKline & French.
Alan is also an expert witness on patent
litigation issues and their commercial impact, working with
leading international law firms.
Other roles have included Chairman of the
Technical Advisory Group for the Access to Medicines Foundation;
guest lecturer at the University of Wales working in the medicines
faculty specialising in pharmaceutical marketing; a long serving
member of the Prescription Medicines Code of Practice Authority
Appeals Board; a Fellow of the Chartered Institute of Management;
Fellow of the International Doctors’ Association and
Member of the Chartered Institute of Marketing.